Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
RISEDRONAT ARENA 35 mg
Bisphosphonate indicated in the treatment and prevention of osteoporosis
Active Substance (INN)
ACIDUM RISEDRONICUM
Packaging
blister x 2; 2 x 4; 3 x 4 FCT
Adverse Reaction Reporting
If you wish to report adverse reactions, please send us the completed adverse reaction reporting form.
Adverse Reaction Form
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.